Previous studies showed that activation of the NLRP3/caspase‐1 pathway contributed to the inflammatory response in the development of various diseases, including pulmonary fibrosis, airway inflammation, and chronic obstructive pulmonary diseases.19, 20. This evidence concerns the gene NLRP3 and pulmonary fibrosis.